相关实验视频

Updated: Jan 10, 2026

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells

Published on: August 7, 2021

减少PPM1B表达驱动PRMT5-介导的质子修饰在肺癌的进展

Attila Makai¹, Ilka Keller², Fanni A Szalmás²

¹Health Care Service Units, Pulmonology Clinic, University of Debrecen Clinical Center, University of Debrecen, H-4032 Debrecen, Hungary.

|November 27, 2025

概括

肺癌中PPM1B表达的减少激活了涉及肌酸酸酶和PRMT5.5的致癌途径. 这种表观遗传失调抑制了瘤抑制剂,驱动了侵袭性疾病,并将PPM1B作为预后标志物.

科学领域:

在瘤学瘤学.
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.
分子生物学分子生物学

背景情况:

肺癌是一种由复杂的信号和表观遗传失调驱动的侵袭性恶性瘤.
Mg2+/Mn2+依赖蛋白酸酶1B (PPM1B) 在细胞调节中发挥作用.

研究的目的:

在肺癌中研究新的致癌PPM1B/肌酸酸酶 (MP) /蛋白质氨酸甲基转移酶5 (PRMT5) 轴.
确定PPM1B在驱动瘤发生中的作用及其作为预后标记物的潜力.

主要方法:

西方涂抹,PCR和免疫组织化学用于分析蛋白质和基因表达.
评估了PPM1B,MYPT1酸化,PRMT5酸化和组蛋白H2A二甲基化的表达水平.

主要成果:

在状细胞癌 (SCC) 和肺腺癌 (ADC) 中,PPM1B表达显著降低,与患者存活率较差相关.
由于MYPT1的抑制酸化升高而导致MP的非激活,并观察到PRMT5的激活酸化增加.
基因组H2A的高对称二甲基化导致视网膜母细胞瘤蛋白表达的降低,这表明瘤抑制基因的表观遗传抑制.

结论:

减少PPM1B表达驱动MP/PRMT5轴的致癌激活,有助于肺癌的攻击性,特别是SCC.
PPM1B作为肺癌的潜在预后标志物,突出了一个新的治疗标.

关键词:

腺癌瘤是一种腺癌.肺癌是一种肺癌.甲基化处理的方法细胞平面癌细胞癌.蛋白质氨酸甲基转移酶5 5 蛋白质酸酶是一种蛋白质酸酶.

更多相关视频

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...